PL1976842T3 - Modulatory nikotynowych receptorów acetocholinowych alfa 7 i ich terapeutyczne zastosowanie - Google Patents
Modulatory nikotynowych receptorów acetocholinowych alfa 7 i ich terapeutyczne zastosowanieInfo
- Publication number
- PL1976842T3 PL1976842T3 PL07702835T PL07702835T PL1976842T3 PL 1976842 T3 PL1976842 T3 PL 1976842T3 PL 07702835 T PL07702835 T PL 07702835T PL 07702835 T PL07702835 T PL 07702835T PL 1976842 T3 PL1976842 T3 PL 1976842T3
- Authority
- PL
- Poland
- Prior art keywords
- nicotinic acetylcholine
- modulators
- therapeutic uses
- acetylcholine receptors
- alpha7 nicotinic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74314206P | 2006-01-18 | 2006-01-18 | |
| PCT/EP2007/000381 WO2007082731A1 (en) | 2006-01-18 | 2007-01-17 | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| EP07702835A EP1976842B1 (en) | 2006-01-18 | 2007-01-17 | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1976842T3 true PL1976842T3 (pl) | 2010-07-30 |
Family
ID=38042829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07702835T PL1976842T3 (pl) | 2006-01-18 | 2007-01-17 | Modulatory nikotynowych receptorów acetocholinowych alfa 7 i ich terapeutyczne zastosowanie |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1976842B1 (pl) |
| JP (1) | JP2009523747A (pl) |
| CN (1) | CN101374826A (pl) |
| AT (1) | ATE460404T1 (pl) |
| AU (1) | AU2007207149A1 (pl) |
| CA (1) | CA2637411A1 (pl) |
| DE (1) | DE602007005225D1 (pl) |
| ES (1) | ES2339816T3 (pl) |
| IL (1) | IL192864A0 (pl) |
| PL (1) | PL1976842T3 (pl) |
| WO (1) | WO2007082731A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2685266C (en) | 2007-04-27 | 2014-01-28 | Purdue Pharma L.P. | Trpv1 antagonists and uses thereof for the treatment of prevention of pain, ui and ulcer, ibd, or ibs in an animal |
| US9273043B2 (en) | 2011-06-22 | 2016-03-01 | Purdue Pharma L.P. | TRPV1 antagonists including dihydroxy substituent and uses thereof |
| CN103524515B (zh) | 2012-07-03 | 2016-07-06 | 浙江海正药业股份有限公司 | 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
| CN104837820A (zh) * | 2012-10-02 | 2015-08-12 | 大日本住友制药株式会社 | 咪唑衍生物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
-
2007
- 2007-01-17 CN CNA2007800032388A patent/CN101374826A/zh active Pending
- 2007-01-17 PL PL07702835T patent/PL1976842T3/pl unknown
- 2007-01-17 AU AU2007207149A patent/AU2007207149A1/en not_active Abandoned
- 2007-01-17 CA CA002637411A patent/CA2637411A1/en not_active Abandoned
- 2007-01-17 JP JP2008550681A patent/JP2009523747A/ja not_active Withdrawn
- 2007-01-17 WO PCT/EP2007/000381 patent/WO2007082731A1/en active Application Filing
- 2007-01-17 DE DE602007005225T patent/DE602007005225D1/de active Active
- 2007-01-17 AT AT07702835T patent/ATE460404T1/de not_active IP Right Cessation
- 2007-01-17 ES ES07702835T patent/ES2339816T3/es active Active
- 2007-01-17 EP EP07702835A patent/EP1976842B1/en active Active
-
2008
- 2008-07-17 IL IL192864A patent/IL192864A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007082731A1 (en) | 2007-07-26 |
| ATE460404T1 (de) | 2010-03-15 |
| DE602007005225D1 (de) | 2010-04-22 |
| EP1976842A1 (en) | 2008-10-08 |
| JP2009523747A (ja) | 2009-06-25 |
| AU2007207149A1 (en) | 2007-07-26 |
| ES2339816T3 (es) | 2010-05-25 |
| CN101374826A (zh) | 2009-02-25 |
| EP1976842B1 (en) | 2010-03-10 |
| CA2637411A1 (en) | 2007-07-26 |
| IL192864A0 (en) | 2009-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007098826A3 (en) | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof | |
| MX2007000669A (es) | Moduladores de receptores acetilcolina nicotinicos alfa 7 y sus usos terapeuticos. | |
| MX2010003375A (es) | Derivados de 1h-indol-3-carboxilato de quinuclidin-4-ilmetilo como ligandos del receptor de acetilcolina alfa 7 nicotinico para el tratamiento de enfermedad de alzheimer. | |
| TW200531689A (en) | Therapeutic agents | |
| WO2006074428A3 (en) | Cxcr4 antagonists for the treatment of medical disorders | |
| UA98317C2 (ru) | СОЕДИНЕНИЯ С АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ НИКОТИНОВОГО АЦЕТИЛХИНОЛИНОВОГО РЕЦЕПТОРА α7 (α7-NACHR), КОМПОЗИЦИЯ, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
| JO2686B1 (en) | Vehicles | |
| WO2007111864A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
| WO2008007211A8 (en) | Substituted n-bicyclicalkyl bicyclic carboxyamide compounds | |
| TN2009000111A1 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
| PL1828179T3 (pl) | Ligandy dla receptorów nikotynowych alfa-7 przeciwko chorobom związanym z OUN | |
| WO2007136577A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
| WO2008021851A3 (en) | Novel compounds as antagonists or inverse agonists for opioid receptors | |
| WO2007110868A3 (en) | Heterocyclic compounds and uses thereof in the treatment of sexual disorders | |
| UA83659C2 (ru) | Антагонисты рецепторов p2x7 и их применение, фармацевтическая композиция на их основе, способ их получения (варианты) | |
| CL2009000697A1 (es) | Compuestos derivados de 2-heteroaril-6-fenil-imidazol [1,2-a]piridinas sustituidas; moduladores de receptores not; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de cancer, inflamacion, enfermedades neurodegenerativas, psiquiatricas, epilepsia, entre otras. | |
| PL1979355T3 (pl) | Pochodne spiro imidazoli jako modulatory PPAR | |
| WO2009082038A3 (en) | Ampa receptor antagonists and zonisamide for epilepsy | |
| WO2008097924A3 (en) | Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders | |
| WO2006035282A3 (en) | Muscarinic receptor antagonists | |
| MX2010006388A (es) | Bis-piridilpiridonas como antagonistas del receptor 1 de la hormona concentradora de melanina. | |
| NZ593484A (en) | Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide | |
| PL1853232T3 (pl) | Trwałe postaci krystaliczne mesylanu bifeprunoksu, postaci dawkowania oraz sposoby ich stosowania | |
| WO2007118151A3 (en) | Spirocyclic heterocyclic derivatives and methods of their use | |
| WO2006054162A8 (en) | Azabicyclic muscarinic receptor antagonists |